Financial Statements · Financial Reporting
Takeda Pharma OÜ
Official identifier 10323690Record date 31 Mar 2023
Report
- Legal formThe legal or organisational form recorded by the Estonian Business Register. Learn more
- OÜ
- Report status
- Registered
Dates
- Reporting year
- 2022
- Period start
- 1 Apr 2022
- Submitted date
- 22 Sep 2023
Report
- Consolidated
- No
- Audited
- Yes
Financial metrics
| Statement | Metric | Value |
|---|---|---|
| Balance sheet | Assets | 2,613,000 |
| Balance sheet | Cash and cash equivalents | 114,000 |
| Balance sheet | Current assets | 2,316,000 |
| Balance sheet | Current liabilities | 502,000 |
| Balance sheet | Equity | 1,965,000 |
| Balance sheet | Share capital at nominal value | 141,000 |
| Balance sheet | Non-current assets | 297,000 |
| Balance sheet | Non-current liabilities | 146,000 |
| Balance sheet | Retained earnings (loss) from previous periods | 389,000 |
| Kahjumi katmise ettepanek | Retained earnings (loss) from previous periods | 389,000 |
| Income statement scheme 1 | Depreciation and impairment of non-current assets | 0 |
| Income statement scheme 1 | Labour costs | 0 |
| Income statement scheme 1 | Revenue | 1,870,000 |
| Income statement scheme 1 | Annual period profit / loss | 85,000 |
| Income statement scheme 1 | Operating profit (loss) | 72,000 |
| Income statement scheme 1 | Profit (loss) before income tax | 85,000 |
| Note: Labour costs | Employees | 10 |
| Note: Labour costs | Labour costs | -853,000 |
Linked company
Company: Takeda Pharma OÜ